155 related articles for article (PubMed ID: 26536461)
1. Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042).
Fernández-Guizán A; López-Soto A; Acebes-Huerta A; Huergo-Zapico L; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S
PLoS One; 2015; 10(11):e0140786. PubMed ID: 26536461
[TBL] [Abstract][Full Text] [Related]
2. The activity of a novel mithramycin analog is related to its binding to DNA, cellular accumulation, and inhibition of Sp1-driven gene transcription.
Fernández-Guizán A; Mansilla S; Barceló F; Vizcaíno C; Núñez LE; Morís F; González S; Portugal J
Chem Biol Interact; 2014 Aug; 219():123-32. PubMed ID: 24907531
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide modulation of gene transcription in ovarian carcinoma cells by a new mithramycin analogue.
Vizcaíno C; Núñez LE; Morís F; Portugal J
PLoS One; 2014; 9(8):e104687. PubMed ID: 25110883
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of mithramycin DIG-MSK can depend on the rise of autophagy.
Vizcaíno C; Rodríguez-Sánchez MA; Núñez LE; Morís F; Portugal J
Toxicol In Vitro; 2015 Oct; 29(7):1537-44. PubMed ID: 26079942
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma.
Tornin J; Martinez-Cruzado L; Santos L; Rodriguez A; Núñez LE; Oro P; Hermosilla MA; Allonca E; Fernández-García MT; Astudillo A; Suarez C; Morís F; Rodriguez R
Oncotarget; 2016 May; 7(21):30935-50. PubMed ID: 27105533
[TBL] [Abstract][Full Text] [Related]
6. Novel mithramycins abrogate the involvement of protein factors in the transcription of cell cycle control genes.
Vizcaíno C; Mansilla S; Núñez LE; Méndez C; Salas JA; Morís F; Portugal J
Biochem Pharmacol; 2012 Nov; 84(9):1133-42. PubMed ID: 22981341
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts.
Previdi S; Malek A; Albertini V; Riva C; Capella C; Broggini M; Carbone GM; Rohr J; Catapano CV
Gynecol Oncol; 2010 Aug; 118(2):182-8. PubMed ID: 20452660
[TBL] [Abstract][Full Text] [Related]
8. A novel mithramycin analogue with high antitumor activity and less toxicity generated by combinatorial biosynthesis.
Núñez LE; Nybo SE; González-Sabín J; Pérez M; Menéndez N; Braña AF; Shaaban KA; He M; Morís F; Salas JA; Rohr J; Méndez C
J Med Chem; 2012 Jun; 55(12):5813-25. PubMed ID: 22578073
[TBL] [Abstract][Full Text] [Related]
9. BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents.
Yoo HJ; Kim BR; Byun HJ; Park SY; Rho SB
Int J Biochem Cell Biol; 2013 Jul; 45(7):1236-45. PubMed ID: 23579097
[TBL] [Abstract][Full Text] [Related]
10. Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factors.
Otjacques E; Binsfeld M; Rocks N; Blacher S; Vanderkerken K; Noel A; Beguin Y; Cataldo D; Caers J
PLoS One; 2013; 8(5):e62818. PubMed ID: 23667526
[TBL] [Abstract][Full Text] [Related]
11. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
12. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine.
Ferreira AK; Freitas VM; Levy D; Ruiz JL; Bydlowski SP; Rici RE; Filho OM; Chierice GO; Maria DA
PLoS One; 2013; 8(3):e57937. PubMed ID: 23516420
[TBL] [Abstract][Full Text] [Related]
14. Cellular response and activation of apoptosis by mithramycin SK in p21(WAF1)-deficient HCT116 human colon carcinoma cells.
Bataller M; Méndez C; Salas JA; Portugal J
Cancer Lett; 2010 Jun; 292(1):80-90. PubMed ID: 19962819
[TBL] [Abstract][Full Text] [Related]
15. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.
Albertini V; Jain A; Vignati S; Napoli S; Rinaldi A; Kwee I; Nur-e-Alam M; Bergant J; Bertoni F; Carbone GM; Rohr J; Catapano CV
Nucleic Acids Res; 2006; 34(6):1721-34. PubMed ID: 16571899
[TBL] [Abstract][Full Text] [Related]
16. Penduliflaworosin, a Diterpenoid from Croton crassifolius, Exerts Anti-Angiogenic Effect via VEGF Receptor-2 Signaling Pathway.
Liang Y; Zhang Y; Wang G; Li Y; Huang W
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098802
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor angiogenesis effect of a new compound: B-9-3 through interference with VEGFR2 signaling.
Ma Q; Chen W; Chen W
Tumour Biol; 2016 May; 37(5):6107-16. PubMed ID: 26611645
[TBL] [Abstract][Full Text] [Related]
18. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer.
Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W
Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616
[TBL] [Abstract][Full Text] [Related]
19. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA
Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055
[TBL] [Abstract][Full Text] [Related]
20. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
